% Expired Patents = 60.0

CIPO Patents = 1

Forward Citations = 128

Loading Chart...

6 inventors (with patents filed for the assignee):

Mark E Davis (5 out of 137 patents)

Jianjun Cheng (5 out of 23 patents)

Kay T Khin (4 out of 15 patents)

4. Suzie Hwang Pun (1 out of 7 patents)

5. Nathalie C Bellocq (1 out of 7 patents)

6. Hector Gonzalez (1 out of 11 patents)

7. Jianjun Cheng (22 patents)

5 patents: Sort by Forward Citations

1. 8404662 - Cyclodextrin-based polymers for therapeutics delivery (2013-03-26),

2. 8399431 - Cyclodextrin-based polymers for therapeutics delivery (2013-03-19),

3. 8389499 - Cyclodextrin-based polymers for therapeutics delivery (2013-03-05),

4. 7270808 - Cyclodextrin-based polymers for therapeutics delivery (2007-09-18),

5. 7018609 - Compositions containing inclusion complexes (2006-03-28),

Insert Therapeutics, Inc. is a biopharmaceutical company specializing in developing novel drug delivery systems. Their proprietary technology platform allows for targeted delivery of therapeutics, improving efficacy and reducing side effects. With a focus on oncology and infectious diseases, Insert Therapeutics aims to revolutionize the way drugs are administered and enhance patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#94 in Pasadena, CA

#12,058 in California

#51,570 in US

Pasadena, CA, United States of America

Insert Therapeutics, Inc.